DFTX

Definium Therapeutics
$42.65
−$0.52 (−1.2%)Jul 27, 2026
2.7FairMoatMint rating

MoatMint rates Definium Therapeutics (DFTX) 2.7 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 0.5 out of 10.

Key metrics

The numbers that frame DFTX today
Market cap
$4.65B
P/E (TTM)
-19.6
EV / FCF
-30.6
ROIC
-153.8%
Div yield
0%
Debt / equity
0.1
52wk Low
$7.96
52wk High
$49.20

DFTX stock rating

How DFTX scores on quality, value, growth, momentum and financial health
2.7out of 10
Fair overallNeutral business, expensive priceTop 73% of ~5,000 US stocks
QualityPoor0.5/10
GrowthPoor1.0/10
MomentumGreat9.9/10
ValueFair3.1/10
Financial HealthFair3.6/10

Growth

Revenue and earnings trend for DFTX
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about DFTX
Is Definium Therapeutics a good buy?
Hold. Definium Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Definium Therapeutics is selling at a high price.
What is the market capitalization of DFTX?
Definium Therapeutics's market capitalization is $4.65B.
What is the P/E ratio for DFTX stock?
Definium Therapeutics's current P/E ratio is -19.6.
What is the 52-week high for DFTX stock?
The 52-week high for Definium Therapeutics is $49.20. The current close of $42.65 is 13.3% below that high.
What is the 52-week low for DFTX stock?
The 52-week low for Definium Therapeutics is $7.96. The current close of $42.65 is 435.8% above that low.
Does DFTX stock pay dividends?
Definium Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for DFTX?
Definium Therapeutics's Debt / Equity ratio is 0.15.